secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001104659-22-028121
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kiora receives Nasdaq deficiency notice for bid price below $1.00; CFO resigns
------------------------------------------------------------------------------

- Nasdaq notified Kiora on Feb 23, 2022 that its stock closed below $1.00 for 30 consecutive business days.
- Company has 180 days (until Aug 22, 2022) to regain compliance by closing >= $1.00 for at least 10 consecutive trading days.
- CFO Sarah Romano resigned effective Feb 25, 2022; Corporate Controller Michael Meluzio appointed as principal financial and accounting officer.
- Kiora evaluating options to regain compliance; may seek additional 180-day period if eligible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922028121/0001104659-22-028121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922028121/tm227887d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-028121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer